ImExHS Past Earnings Performance

Past criteria checks 0/6

ImExHS has been growing earnings at an average annual rate of 13.2%, while the Healthcare Services industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 22.8% per year.

Key information

13.2%

Earnings growth rate

30.6%

EPS growth rate

Healthcare Services Industry Growth42.6%
Revenue growth rate22.8%
Return on equity-22.7%
Net Margin-13.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Investors Don't See Light At End Of ImExHS Limited's (ASX:IME) Tunnel And Push Stock Down 26%

Nov 28
Investors Don't See Light At End Of ImExHS Limited's (ASX:IME) Tunnel And Push Stock Down 26%

ImExHS Limited (ASX:IME) Might Not Be As Mispriced As It Looks

Jun 27
ImExHS Limited (ASX:IME) Might Not Be As Mispriced As It Looks

Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet

Jan 02
Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet

ImExHS Limited (ASX:IME) Screens Well But There Might Be A Catch

Jun 07
ImExHS Limited (ASX:IME) Screens Well But There Might Be A Catch

Is ImExHS (ASX:IME) Using Too Much Debt?

Mar 09
Is ImExHS (ASX:IME) Using Too Much Debt?

Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)

Mar 19
Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)

Did You Miss ImExHS' (ASX:IME) 60% Share Price Gain?

Feb 11
Did You Miss ImExHS' (ASX:IME) 60% Share Price Gain?

Revenue & Expenses Breakdown

How ImExHS makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:IME Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2425-382
31 Mar 2422-472
31 Dec 2320-461
30 Sep 2318-461
30 Jun 2317-451
31 Mar 2317-361
31 Dec 2217-362
30 Sep 2218-362
30 Jun 2218-461
31 Mar 2216-461
31 Dec 2113-561
30 Sep 2113-461
30 Jun 2112-461
31 Mar 2111-451
31 Dec 2011-451
30 Sep 2010-551
30 Jun 2010-651
31 Mar 209-652
31 Dec 198-652
30 Sep 197-642
30 Jun 197-742
31 Mar 196-632
31 Dec 186-531
30 Sep 185-321
30 Jun 184-110
31 Mar 184-110
31 Dec 174-110
31 Dec 163010
31 Dec 154010

Quality Earnings: IME is currently unprofitable.

Growing Profit Margin: IME is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IME is unprofitable, but has reduced losses over the past 5 years at a rate of 13.2% per year.

Accelerating Growth: Unable to compare IME's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IME is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (19%).


Return on Equity

High ROE: IME has a negative Return on Equity (-22.65%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 15:55
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ImExHS Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Iain WilkieMorgans Financial Limited